We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IZEA:NASDAQIZEA Worldwide, Inc. Analysis

Data as of 2026-07-13 - not real-time

$3.58

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

IZEA is trading at $3.58, just under its 20‑day simple moving average of $3.59, and well below both the 50‑day ($3.79) and 200‑day ($4.15) averages, signaling a bearish price structure. The 14‑day RSI sits at 46.5, indicating neutral momentum but edging away from oversold territory. MACD shows a modest bullish crossover with the line above the signal and a positive histogram of 0.014, yet the magnitude is tiny. Volume has been on a downward trajectory, and the 30‑day volatility is a lofty 38.9%, reflecting an erratic trading pattern. The computed beta of 0.44 suggests the stock moves less than the broader market, but the high realized volatility offsets that benefit. Support at $3.34 and resistance near $3.78 frame a narrow trading range that the price has struggled to break upward.
On the fundamentals side, revenue has contracted 17.5% year‑over‑year to roughly $29.8 million, and margins are deep in the red (gross margin 48%, operating margin –17.8%). The company posted a trailing EPS of –$0.03 and a forward EPS of –$0.41, resulting in a negative forward P/E of –8.73, which renders traditional valuation ratios less informative. Nevertheless, the balance sheet is strong, with $46.5 million in cash and virtually no debt (debt‑to‑equity 0.5%). The price‑to‑book of 1.28 and price‑to‑sales of 2.10 are modest compared with industry averages, hinting at a potential value edge. No dividend is paid, and the “Extreme Greed” reading on the Fear & Greed Index (94.6) suggests the market may be overly optimistic despite the weak earnings profile. Given the mix of technical weakness, sizable cash reserves, and a low‑cost valuation, the stock sits at a crossroads between short‑term pressure and a longer‑term turnaround opportunity.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • price below key moving averages
  • decreasing volume and high short‑term volatility
  • negative earnings and revenue decline

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • strong cash position with minimal debt
  • price-to-book and price-to-sales suggest modest undervaluation
  • uncertain path to profitability

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • potential upside from platform scaling and AI tools
  • low beta and sizable liquidity cushion
  • valuation metrics imply upside if turnaround materializes

Key Metrics & Analysis

Financial Health

Revenue Growth-17.50%
Profit Margin-1.98%
P/E Ratio-8.7
ROE-1.23%
ROA-2.58%
Debt/Equity0.01
P/B Ratio1.3
Op. Cash Flow$-3565743
Free Cash Flow$-5409263
Industry P/E16.2

Technical Analysis

TrendBearish
RSI46.6
Support$3.34
Resistance$3.78
MA 20$3.59
MA 50$3.79
MA 200$4.15
MACDBullish
VolumeDecreasing
Fear & Greed Index94.59

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.44
Volatility38.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.